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abstract
Background: Signs indicating hypertensive retinopathy can 
help determine the extent of hypertensive cardiovascular, 
renal and cerebrovascular damage. 
Objectives: To study the association between hypertensive 
retinopathy and cardiovascular, renal and cerebrovascular 
changes, and to determine the predictors of hypertensive 
retinopathy in Congolese patients. 
Methods: A total of 159 hypertensive subjects (mean age: 58.9 
± 13.2 years) were enrolled from the cardiology out-patient 
clinic. Retinopathy grade was assessed on direct ophthalmos-
copy. Hypertensive cardiovascular, renal and cerebrovascular 
changes were indicated by left ventricular hypertrophy (LVH), 
chronic kidney disease (CKD) and stroke, respectively. 
Results: Hypertensive retinopathy was present in 83.6% of 
the patients (grade 1: 42.1%; grade 2: 11.3%; grade 3: 23.3%; 
grade 4: 6.9%). There was no association between hyperten-
sive retinopathy and the presence or absence of LVH (86.5 
vs 73.3%, χ2 = 1.53, p = 0.21), chronic kidney disease (89.3 vs 
83.3%, χ2 = 0.12, p = 0.73) or stroke (85.7 vs 83.2%, χ2 > 0.001, 
p = 0.99). On multivariate logistic regression, CKD was the 
most significant predictor of severe hypertensive retinopathy, 
with an odds ratio of 4.4.
Conclusion: No association was found between hypertensive 
retinopathy and LVH, CKD or stroke. CKD was the most 
significant predictor of hypertensive retinopathy and there 
was a tendency toward increased risk of target-organ damage 
among patients with advanced hypertensive retinopathy.
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lar hypertrophy, chronic kidney disease, stroke
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Hypertension is a major public health problem worldwide and 
on the African continent.1,2 The disease, once considered to be 
rare outside Europe and North America, is now a leading cause 
of disability and mortality in developing countries. Its prevalence 
is projected to reach 30% worldwide by 2025.2 
Poor control of hypertension increases the likelihood of 
complications affecting the cardiovascular and cerebrovascular 
systems, kidney and retina, often labelled under the term target-
organ damage (TOD).1 The development of subclinical TOD, 
such as left ventricular hypertrophy (LVH), increased intima–
media thickness of the large vessels, microalbuminuria following 
glomerular dysfunction, cognitive decline and hypertensive 
retinopathy precedes the occurrence of major complications, 
which include stroke, congestive heart failure and myocardial 
infarction, renal failure and retinal vascular occlusions.3-5 In 
the Democratic Republic of Congo (DRC), the prevalence 
of systemic hypertension has been reported to be over 25%,6,7 
whereas hypertension and associated complications account for 
over 20% of deaths among adults.8 
Studies have demonstrated that TOD increases cardiovascular 
risks over that already associated with elevated blood pressure 
alone. For example, it has been shown that once LVH has 
developed following long-standing systemic hypertension, it 
behaves as an independent risk factor and a predictor of both 
further cardiac complications,9 and other incident vascular 
events such as ischemic stroke and myocardial infarction.10 
Similarly, the presence of cerebrovascular and renal damage may 
raise cardiovascular risk over that conferred by hypertension 
itself.11,12 
In addition, hypertensive retinopathy has long been known 
as a predictor of systemic morbidity and mortality. Both 
epidemiological and clinical studies have provided evidence 
that markers of hypertensive retinopathy  are associated with 
raised blood pressure, systemic vascular diseases, and subclinical 
cerebrovascular and cardiovascular disease, and predict incident 
clinical stroke, congestive heart failure and mortality due to 
cardiovascular complications.13 This association of hypertensive 
retinopathy with other TOD has also been shown to be 
independent of blood pressure and other risk factors, which 
supports the recommendation that retinal vascular changes 
should be assessed in individuals with systemic hypertension for 
better extra-ocular TOD risk stratification.13 
While the number of reports on hypertensive TOD has been 
on the rise on the African continent, the relationship between 
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hypertensive retinopathy and other TOD has largely remained 
unexplored. The aim of this study was to examine the association 
of hypertensive retinopathy with LVH, chronic kidney disease 
(CKD) and stroke in Congolese patients. 
methods
This cross-sectional, observational study included 159 consecutive 
Congolese hypertensive patients (73 men, 86 women, mean age 
57.9 ± 13.2 years) who were referred from the Cardiology 
Division to the Ophthalmology Department of the Kinshasa 
University Hospital for fundus examination as part of a work-up 
of people with hypertension. All participants provided informed 
consent and the study was approved by the University of 
Kinshasa Medical School institutional review board. 
Inclusion criteria were age ≥ 18 years, willingness to participate 
in the study, established diagnosis of hypertension regardless of 
treatment regimen, duration, severity or aetiology. Exclusion 
criteria included inaccessibility of the fundus due to media 
opacities, and pregnancy. 
All participants underwent blood pressure measurement 
with a mercury sphygmomanometer after the patient has been 
in a sitting position for five minutes, and body mass index 
(BMI) determination. They provided personal information 
about history of alcoholism, smoking, as well as family history 
of hypertension and stroke, and diabetes. 
Routine ophthalmological examination was performed, which 
included measurement of visual acuity, slit-lamp examination of 
the anterior segment, intra-ocular pressure measurement with 
applanation tonometry, and ocular fundus assessment with direct 
ophthalmoscopy after pupil dilation with tropicamide 1% and 
phenylephrine 10%. The fundus examination specifically looked 
at retinal abnormalities consistent with hypertensive retinopathy, 
which was graded based on the Scheie classification:14 grade 
0 = no visible change; grade 1 = barely detectable arterial 
narrowing; grade 2 = obvious arterial narrowing with focal 
irregularities; grade 3 = grade 2 plus retinal haemorrhages, 
exudates, cotton wool spots, or retinal oedema; grade 4: grade 3 
plus papilloedema. 
Hypertension was defined and classified according to 
the European Society of Hypertension/European Society of 
Cardiology guidelines.15 Data about extra-ocular TOD such 
as LVH, CKD and stroke were recorded from cardiology 
medical records. LVH was diagnosed by echocardiogram using 
ASE criteria:16 end-systolic left ventricular diameter, septal wall 
thickness (SWT) and posterior wall thickness were calculated 
from the two-dimensionnally guided M-mode tracing and 
measured in five consecutive cardiac cycles. LVH was defined by 
SWT greater than 11 mm. 
CKD was diagnosed according to the Kidney Disease Outcome 
Quality Initiative (K/DOQI),17 when glomerular filtration rate 
(GFR) was lower than 60 ml/min/1.7 m² using the equation from 
the Modified Diet in Renal Disease (MDRD) study.18 Stroke was 
diagnosed in the presence of clinical neurological signs consistent 
with stroke, with or without supporting CT scan lesions. 
Statistical analysis 
All analyses were performed with SPSS version 15.0 (SPSS, 
Chicago, IL, USA). Data were expressed as mean ± standard 
deviation. Student’s t-test was used to compare means between 
groups. The proportion of patients with hypertensive retinopathy 
was compared among those with and without LVH, CKD or 
stroke using the chi-square test. The chi-square test was also 
used to compare the proportions of patients with TOD between 
those with and without hypertensive retinopathy. Multiple 
logistic regression analysis allowed assessment of the association 
of demographic and clinical factors including TOD with the 
likelihood of having hypertensive retinopathy. A p < 0.05 was 
considered statistically significant. 
results
Of the 159 patients included in this study, 73 (46%) were male 
and 86 (54%) were female, with a mean age of 57.9 ± 13.2 years 
(range: 19–92). Approximately half of the patients (48.4%) had 
been hypertensive for one to 10 years; 137 (86.2%) patients had 
essential hypertension and 22 were diabetic. Hypertension was 
grade 1 (systolic: 140–159 mmHg and diastolic: 90–99 mmHg), 
grade 2 (systolic: 160–179 mmHg, diastolic: 100–109 mmHg) 
and grade 3 (systolic ≥ 180 mmHg, diastolic ≥ 110 mmHg) in 
48 (30.2%), 34 (21.4%) and 77 (48.4%) patients, respectively. 
One hundred and twenty-two (76.7%) patients were on blood 
pressure-lowering treatment (57.2% had uncontrolled whereas 
19.5% has controlled blood pressure) and 37 (23.3%) were not 
on treatment at the time of study enrolment. 
Other characteristics of the study population were as follows: 
weight 71.8 ± 16.3 kg (range: 42–130), height 163.5 ± 8.9 cm 
(range: 148–162), waist circumference 90.9 ± 12.8 cm (range: 
67–125), systolic blood pressure 159.1 ± 30.9 mmHg (range: 
100–230), diastolic blood pressure 95.1 ± 16.6 mmHg (range: 
61–157), serum creatinine 2.2 ± 3.6 mg/dl (range: 0.3–19) and 
blood urea 38.9 ± 42.1 mmol/l (range: 5.2–258).
Hypertensive retinopathy stage 0, 1, 2, 3 and 4 was present 
in 16.4, 42.1, 11.3, 23.3 and 6.9% of the patients, respectively. 
Overall, the severity of  hypertensive retinopathy increased 
with increasing systolic and diastolic blood pressures. Data 
on cardiac state were available for 97 (61%) patients, of whom 
52 (53.6%) had LVH. Twenty-eight (31.8%) of the 88 patients 
who underwent glomerular filtration rate (GFR) assessment 
had levels consistent with CKD and 28 (17.6%) patients were 
diagnosed as having stroke. 
Table 1 shows the distribution of patients with LVH by stage 
of retinopathy. The proportions of patients with retinopathy 
were comparable among those with (86.5%) and without LVH 
(73.3%) (χ2 = 1.53, p = 0.21). Similarly, the proportions of 
patients with LVH did not differ significantly between patients 
with (57.7%) and those without retinopathy (36.8%) (χ2 = 
0.39, p = 0.53). There was no significant association between 
hypertensive retinopathy and LVH (χ2 = 1.9, p = 0.17, OR = 2.3, 
95% CI: 0.8–6.6). For all retinopathy stages, the proportions of 
patients with and without LVH were comparable (p = 0.24–0.99, 
data not provided in Table 1). The risk of having LVH tended to 
increase with the severity of hypertensive retinopathy; it was 4.5 
times higher for patients with grade 3 hypertensive retinopathy 
relative to those without retinopathy. 
There were 28 patients with CKD; their distribution by 
retinopathy stage is provided in Table 2. Subgroups of patients 
with and without retinopathy had similar proportions of patients 
with CKD (33.3 vs 23.1%) (χ2 = 0.088, p = 0.77). A similar 
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observation was made regarding the proportions of patients with 
hypertensive retinopathy among those with and without CKD 
(89.3 vs 83.3%) (χ2 = 0.12, p = 0.73). The association of CKD with 
hypertensive retinopathy was not significant for all retinopathy 
stages combined (χ2 = 0.17, p = 0.68, OR = 1.7, 95% CI: 0.4–6.6) 
or for each retinopathy stage taken individually (χ2 = 0.03–2.82, 
p = 0.09–0.85). Compared to patients without hypertensive 
retinopathy, those with stages 3 and 4 hypertensive retinopathy 
were 3.3 and 13.3 times more likely to have CKD, respectively.
There were 85.7% of patients with hypertensive retinopathy 
among those who suffered from stroke (28 patients, Table 
3). This proportion was not significantly different from the 
83.2% of patients with hypertensive retinopathy among those 
without stroke (χ2 > 0.001, p = 0.99). Patients with hypertensive 
retinopathy were as likely as those without retinopathy to have 
stroke (18 vs 15.4%) (χ2 = 0.34, p = 0.56). No association was 
found between stroke and hypertensive retinopathy regardless 
of retinopathy stage (χ2 < 0.01, p = 0.96, OR = 1.2; 95% CI: 
0.4–3.8) and for individual retinopathy stages (χ2 = 0.02–1.06, p 
= 0.30–0.88). 
A subset of data of 75 patients with complete documentation 
was used to perform a multivariate logistic regression analysis 
that included age, gender, BMI, alcohol consumption, smoking, 
diabetes, arterial pressures (systolic, diastolic and pulse), current 
blood pressure-lowering treatment, LVH, CKD and stroke as 
candidate explanatory variables, and hypertensive retinopathy 
as outcome variable after controlling for diabetes. The results, 
shown in Table 4, indicate that CKD was the most significant 
predictor of hypertensive retinopathy, with OR of 4.4 compared 
to CKD-free patients. Age > 50 years and smoking appeared to 
decrease the risk of hypertensive retinopathy; the effects were 
negligible but significant.
discussion 
Hypertension is an important cause of morbidity and mortality 
in the general population in Western countries, and recent 
surveys in sub-Saharan Africa have reported high prevalences 
of hypertension ranging between 19 and 50% in both urban 
and rural populations.19,20 If  left untreated, hypertension may 
result in considerable damage to the cardiovascular, renal 
and cerebrovascular systems, leading to such complications as 
myocardial infarction, CKD and cerebrovascular accident. 
While significant efforts have been invested to demonstrate 
the benefits of antihypertensive treatment, it is critical for 
better management to know both to what extent the various 
hypertension-related TODs are interrelated, and the risk factors 
for hypertension-related damage. Because studies in this regard 
are limited in sub-Saharan Africa, we investigated the relationship 
between hypertensive retinopathy and LVH, CKD and stroke 
among Congolese patients. We also assessed the determinants of 
hypertensive retinopathy. 
It has been hypothesised that both hypertension-related 
retinal and renal vascular changes share common pathogenetic 
mechanisms. As a result, earlier studies have consistently reported 
an association between the presence of retinal vascular changes 
associated with hypertension and lower GFR.21-23 Surprisingly, 
our results suggest otherwise, which may be ascribed to the small 
study population. 
Signs of  hypertensive retinopathy have also long been 
recognised as risk indicators of LVH, both in population- and 
hospital-based studies.24-26 For example, in the Chronic Renal 
Insufficiency Cohort (CRIC) study,26 there was an association 
between severity of hypertensive retinopathy and the incidence 
of any cardiovascular disease. Similarly, a follow up of the 
National Health and Nutrition Survey (NHANES I) reported 
an increased risk of cardiovascular disease in people with 
hypertensive ocular fundus retinal vascular changes.27 
The lack of association between hypertensive retinopathy 
and LVH found in our study echoes the findings of other earlier 
studies.28,29 While there is a general agreement on the association 
between hypertensive retinopathy and all types of hypertensive 
cardiovascular diseases,26,27,30 our study only focused on LVH, 
which may explain the lack of association. Overall, our findings 
corroborate those of earlier studies that the risk of developing 
LVH increases significantly with the severity of hypertensive 
retinopathy.
table 1. association between hypertensive retinopathy  











0 7 (13.5) 12 (26.7) 1 – –
1 19 (36.5) 21 (46.7) 1.6 (0.5–4.8) 0.24 0.62
2 10 (19.2) 5 (11.1) 3.4 (0.8–14.2) 1.91 0.17
3 13 (25.0) 5 (11.1) 4.5 (1.1–17.9) 3.34 0.07
4 3 (5.8) 2 (4.4) 2.6 (0.3–19.3) 0.18 0.67
OR: odd ratio, CI: confidence interval.
table 2. association between hypertensive retinopathy  











0 3 (10.7) 10 (16.6) 1 – –
1 9 (32.1) 26 (43.3) 1.2 (0.3–5.2) 0.04 0.85
2 2 (7.1) 13 (21.7) 0.5 (0.07–3.7) 0.03 0.86
3 10 (35.7) 10 (16.7) 3.3 (0.7–15.9) 1.4 0.24
4 4 (14.3) 1 (1.7) 13.3 (1.1–169.1) 2.8 0.09
OR: odd ratio, CI: confidence interval.












0  4 (14.3) 22 (16.8) 1 - -
1 11 (39.3) 56 (42.7) 1.1 (0.3–3.8) 0.04 0.85
2  6 (21.4) 12 (9.2) 2.8 (0.7–11.7) 1.1 0.30
3  4 (14.3) 33 (25.2) 0.7 (0.2–2.9) 0.02 0.88
4  3 (10.7) 8 (6.1) 2.1 (0.4–11.3) 0.2 0.70
OR: odd ratio, CI: confidence interval.
table 4. significant determinants of hypertensive retinopathy
Parameters β p-value OR (95% CI)
Constant  –0.88 0.23 0.41 
Chronic kidney disease  1.49 0.018  4.4 (1.29–15.21)
Age > 50 years  –1.46 0.046  0.23 (0.06–0.97)
Smoking  –2.02 0.035  0.1 (0.02–0.9)
OR: odd ratio, CI: confidence interval.
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In support of Cuspidi et al.,31 the frequency of severe 
retinopathy (i.e. grade 4) appeared to be low among subjects 
with LVH. The same observation was made among subjects 
with CKD as well as those with stroke. While we do not have 
a definitive explanation for this observation, it is possible 
that hypertensive patients in our setting have a reduced life 
expectancy so that severe retinopathy has no time to develop. 
Hypertensive retinopathy had no association with stroke 
in this study, which is at odds with reports from earlier 
investigations. Indeed, many cross-sectional studies have 
demonstrated a clear relationship between hypertensive ocular 
fundoscopic abnormalities and both clinical and subclinical 
stroke, even after adjusting for other independent vascular risk 
factors.32-34 However, definitive convincing evidence in favour of 
this association has been provided by longitudinal studies.35-39 
Unlike most of these earlier studies that used ocular fundus 
photography and brain imaging techniques to increase the 
diagnostic accuracy, our diagnosis of stroke was clinical and 
retrospective in nature. As a result, a substantial number of 
patients who suffered subclinical stroke and/or hypertensive 
retinopathy, identifiable using imaging techniques, may have 
been unaccounted for. The cost of medical imaging modalities 
such as CT scans limits the patient’s access to this sensitive 
diagnostic tool. This limitation is also valid for the association 
between LVH and hypertensive retinopathy.
Studies on predictors of hypertensive retinopathy have 
reported conflicting results. For example, while aging, obesity 
measured by BMI, and smoking have been traditionally 
associated with increased risk of hypertensive retinopathy, Sharp 
et al.40 found that age and systolic blood pressure did not 
influence hypertensive retinopathy in people of African origin, 
despite a higher prevalence of hypertensive retinopathy in this 
group compared to people of European descent.
In the ARIC study,35 only mean blood pressure was associated 
with hypertensive retinopathy in the subset of participants of 
African descent. LVH and BMI were not significant determinants, 
and smoking had a marginally non-significant effect. The risk-
reducing effect of aging, smoking, and LVH on retinopathy that 
we found is surprising and adds to existing inconsistencies in 
results across studies. We speculated that higher mortality rates, 
selectively affecting older people as a result of hypertension-
related complications, and other morbidities in our setting may 
contribute to the inverse ORs observed for age and LVH. 
Because arteriolar narrowing and arteriovenous nipping can 
be found in the absence of hypertension, it has been argued 
that these signs have little or no value in the management of 
hypertension, and that clear evidence is lacking to show that 
patients with mild hypertensive retinopathy need physician 
referral or follow up. Conversely, landmark prospective studies 
have provided evidence of the clinical value of retinal arteriolar 
narrowing. For example, in the Beaver Dam Eye study,41 the five-
year incidence of retinopathy in general and that of arteriolar 
narrowing was significantly higher in patients with elevated 
blood pressure, despite being on antihypertensive treatment, 
relative to those with controlled blood pressure and those with 
no hypertension. 
The Blue Mountain Eye study42 reported an association 
between generalised retinal arteriolar narrowing at baseline 
and about a three-fold increased risk of five-year incidents 
of severe hypertension. These findings emphasise the clinical 
value of assessing retinal arteriolar change for cardiovascular 
risk prediction, and are supported by international guidelines 
for hypertension management such as the US Joint National 
Committee on Prevention, Detection, Evaluation and Treatment 
of High Blood Pressure, the European Society of Cardiology, 
the European Society of Hypertension, and the British Society 
of Hypertension.
We acknowledge that this study has some limitations. The 
diagnosis of  hypertensive retinopathy, particularly in the 
early stages, has been shown to suffer from high rates of 
inter- and intra-observer variability when assessed with direct 
ophthalmoscopy, as in this study. Because only one observer 
made the assessment and there was no intra-observer, the results 
presented herein did not account for the possible effect of low 
reliability. An additional limitation that may have influenced the 
results is the small number of study participants who underwent 
GFR assessment and echocardiogram, which may limit the 
generalisability of our findings.
Conclusion
There was no association between hypertensive retinopathy and 
LVH, CKD or stroke in this series. There was a trend towards 
increased risk for developing TOD among people with advanced 
retinopathy. CKD emerged as the only significant predictor of 
hypertensive retinopathy. 
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